Clinical Trials Directory

Trials / Completed

CompletedNCT03918343

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Study of Lipopolysaccharide Metabolism for Identification of New Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study is designed to assess the hypothesis that the lipopolysaccharide (LPS) activity index can be quantified early after transplantation, as well as the the PhosphoLipid Transfer Protein (PLTP) activity and these both biological variables are independent variables for predicting the risk of severe Graft versus Host Disease (GVHD).

Conditions

Interventions

TypeNameDescription
OTHERBlood sampleblood samples (4 times; 14ml per visit)

Timeline

Start date
2019-09-06
Primary completion
2024-09-01
Completion
2025-05-23
First posted
2019-04-17
Last updated
2025-07-09

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03918343. Inclusion in this directory is not an endorsement.

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After A (NCT03918343) · Clinical Trials Directory